The Nazareth Hospital, Israel
9
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
11%
1 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients
Role: collaborator
Group B Streptococcal Carrier State Prevalence Among Arab Pregnant Women in Northern Israel District
Role: lead
Effects of Carnitine on Oxidative Stress to IVIR Administration to CKD Patients:Impact of Haptoglobin Genotype
Role: lead
Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis
Role: lead
Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation
Role: lead
Detection and Identification of Preeclampsia Via Volatile Biomarkers
Role: lead
Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression
Role: collaborator
Early Detection and Characterization of Primary Ciliary Dyskinesia
Role: collaborator
Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Role: lead
All 9 trials loaded